| Application no. and date | 15731976.5 (espacenet) (Federated) (European Patent Register), 20150701 | | Patent/reg. no. and date | DK/EP 3164414, 20200401 | | Publication date | 20170510 | | Priority no. and date | EP 14175361, 20140702 | | EP pub. no. and date |
EP 3164414 20170510 | | Effective date | | | Applicant/owner | Novartis Pharma AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | BT/GP/160451 | | Inventor | LEGER, Olivier, 603 route des Luches
74800 Saint-Sixt, FR,
Vicari, Alain, 32 La Ruelle
74160 Neydens, FR | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , C07K 16/24 (2006.01) , G01N 33/68 (2006.01) | | Title | Antistoffer for IL-15 | | Int. application no. | EP2015064931 | | Int. publication no. | WO2016001275 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
